Abczf News Today

Abcam (OTCMKTS:ABCZF – Get Free Report) is one of 373 public companies in the “Biotechnology” industry, but how does it weigh in compared to its rivals? We will compare Abcam to similar companies based on the strength of its risk, analyst recommendations, institutional ownership, profitability, valuation, earnings and dividends. Profitability This table compares Abcam and […]

Abcam (OTCMKTS:ABCZF – Get Free Report) is one of 449 public companies in the “Biotechnology” industry, but how does it compare to its rivals? We will compare Abcam to similar companies based on the strength of its analyst recommendations, dividends, institutional ownership, profitability, valuation, earnings and risk. Earnings & Valuation This table compares Abcam and […]

Abcam (OTCMKTS:ABCZF – Get Free Report) is one of 449 public companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Abcam to similar businesses based on the strength of its profitability, risk, valuation, analyst recommendations, institutional ownership, dividends and earnings. Profitability This table compares Abcam and […]

Abcam (OTCMKTS:ABCZF – Get Free Report) is one of 397 public companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Abcam to similar businesses based on the strength of its dividends, risk, valuation, profitability, earnings, institutional ownership and analyst recommendations. Dividends Abcam pays an annual dividend […]

Abcam (OTCMKTS:ABCZF – Get Free Report) is one of 380 public companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Abcam to similar companies based on the strength of its dividends, profitability, earnings, institutional ownership, risk, valuation and analyst recommendations. Insider and Institutional Ownership 43.6% of […]

Abcam (OTCMKTS:ABCZF – Get Free Report) is one of 373 public companies in the “Biotechnology” industry, but how does it contrast to its rivals? We will compare Abcam to related companies based on the strength of its institutional ownership, risk, analyst recommendations, dividends, valuation, profitability and earnings. Profitability This table compares Abcam and its rivals’ […]

Abcam (OTCMKTS:ABCZF – Free Report) is one of 360 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare Abcam to related companies based on the strength of its profitability, analyst recommendations, dividends, earnings, valuation, institutional ownership and risk. Profitability This table compares Abcam and its competitors’ net […]

Abcam (OTCMKTS:ABCZF – Free Report) is one of 362 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare Abcam to similar businesses based on the strength of its valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and earnings. Analyst Recommendations This is a summary of recent ratings […]

Abcam plc (OTCMKTS:ABCZF – Get Rating) saw a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 31,400 shares, a decline of 77.4% from the May 15th total of 139,200 shares. Based on an average daily trading volume, of 200 shares, the short-interest ratio is […]

Abcam Plc (OTCMKTS:ABCZF – Get Rating) saw a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 236,500 shares, a growth of 56.2% from the January 31st total of 151,400 shares. Based on an average daily volume of 500 shares, the short-interest ratio is presently […]